S&P 500   3,351.33 (+0.00%)
DOW   27,685.79 (+0.92%)
QQQ   268.40 (-1.13%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
S&P 500   3,351.33 (+0.00%)
DOW   27,685.79 (+0.92%)
QQQ   268.40 (-1.13%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
S&P 500   3,351.33 (+0.00%)
DOW   27,685.79 (+0.92%)
QQQ   268.40 (-1.13%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
S&P 500   3,351.33 (+0.00%)
DOW   27,685.79 (+0.92%)
QQQ   268.40 (-1.13%)
AAPL   447.31 (+0.64%)
MSFT   207.80 (-2.20%)
FB   263.54 (-1.83%)
GOOGL   1,488.98 (-0.63%)
AMZN   3,132.80 (-1.09%)
NVDA   445.25 (-0.61%)
CGC   18.14 (+9.08%)
BABA   247.17 (-1.96%)
TSLA   1,423.20 (-2.03%)
MU   48.99 (+0.49%)
GE   6.66 (+3.90%)
AMD   81.58 (-3.85%)
T   30.13 (+0.37%)
F   7.09 (+3.35%)
ACB   10.17 (-0.97%)
GILD   68.29 (-1.53%)
NFLX   484.82 (-2.00%)
DIS   129.55 (-0.29%)
BAC   26.66 (+2.11%)
BA   177.74 (+4.54%)
Log in

NASDAQ:GILDGilead Sciences News Headlines

$68.29
-1.06 (-1.53 %)
(As of 08/10/2020 11:52 AM ET)
Add
Compare
Today's Range
$68.13
Now: $68.29
$69.25
50-Day Range
$68.81
MA: $74.95
$78.08
52-Week Range
$60.89
Now: $68.29
$85.97
Volume4.05 million shs
Average Volume8.26 million shs
Market Capitalization$85.62 billion
P/E RatioN/A
Dividend Yield3.92%
Beta0.65

Headlines

Gilead Sciences (NASDAQ GILD) News Headlines

Source:
DateHeadline
Gilead Sciences (NASDAQ:GILD) Given "Hold" Rating at JPMorgan Chase & Co.Gilead Sciences (NASDAQ:GILD) Given "Hold" Rating at JPMorgan Chase & Co.
marketbeat.com - August 7 at 8:30 AM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 6 at 5:47 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 5 at 5:11 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 4 at 5:05 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 3 at 4:42 PM
Good Time to Get in on Earnings-Winner Merck (NYSE: MRK)  (GILD)Good Time to Get in on Earnings-Winner Merck (NYSE: MRK) (GILD)
marketbeat.com - August 3 at 2:09 PM
3 Surprising COVID Stocks That May Continue to Outperform (GILD)3 Surprising COVID Stocks That May Continue to Outperform (GILD)
marketbeat.com - August 3 at 2:09 PM
Gilead Sciences (NASDAQ: GILD): Biomed Play Built on Future Value (GILD)Gilead Sciences (NASDAQ: GILD): Biomed Play Built on Future Value (GILD)
marketbeat.com - August 3 at 2:09 PM
Gilead Sciences: Now is Not the Time to Get Sticker Shock (GILD)Gilead Sciences: Now is Not the Time to Get Sticker Shock (GILD)
marketbeat.com - August 3 at 2:09 PM
Little-Known Apple (AAPL) Subsidiary Set to Gain From Coronavirus (GILD)Little-Known Apple (AAPL) Subsidiary Set to Gain From Coronavirus (GILD)
marketbeat.com - August 3 at 2:08 PM
Biotech Stocks - Best Biotech Stocks to Buy (GILD)Biotech Stocks - Best Biotech Stocks to Buy (GILD)
marketbeat.com - August 3 at 2:08 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 2 at 4:35 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - August 1 at 4:06 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 31 at 3:38 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 30 at 3:21 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 29 at 3:25 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 28 at 3:08 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 27 at 3:17 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 26 at 3:03 PM
These 5 Stocks Save Lives, Fund RetirementsThese 5 Stocks Save Lives, Fund Retirements
marketbeat.com - July 25 at 3:04 PM
GILD Named Top Dividend Stock of the Nasdaq 100 at Dividend Channel With 3.9% YieldGILD Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 3.9% Yield
nasdaq.com - August 10 at 8:17 AM
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Hold" by AnalystsGilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Hold" by Analysts
americanbankingnews.com - August 8 at 11:56 AM
Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from JPMorgan Chase & Co.Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from JPMorgan Chase & Co.
americanbankingnews.com - August 8 at 12:22 AM
Pfizer to make Gileads COVID-19 treatment remdesivirPfizer to make Gilead's COVID-19 treatment remdesivir
finance.yahoo.com - August 7 at 2:47 PM
Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug RemdesivirPfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug Remdesivir
msn.com - August 7 at 2:47 PM
Gilead contracts Pfizer to make COVID drug remdesivirGilead contracts Pfizer to make COVID drug remdesivir
seekingalpha.com - August 7 at 2:47 PM
Pfizer to help manufacture Gileads remdesivirPfizer to help manufacture Gilead's remdesivir
msn.com - August 7 at 9:47 AM
Pfizer signs deal to supply Gilead's remdesivir for COVID-19Pfizer signs deal to supply Gilead's remdesivir for COVID-19
finance.yahoo.com - August 7 at 9:47 AM
Pfizer to help manufacture Gilead's remdesivirPfizer to help manufacture Gilead's remdesivir
finance.yahoo.com - August 7 at 9:46 AM
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatmentNIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment
finance.yahoo.com - August 7 at 9:46 AM
Rex Nutting: Gilead is protecting its drug patent instead of protecting COVID-19 patientsRex Nutting: Gilead is protecting its drug patent instead of protecting COVID-19 patients
marketwatch.com - August 7 at 9:02 AM
Gilead ups supply of remdesivir 50-fold since JanuaryGilead ups supply of remdesivir 50-fold since January
seekingalpha.com - August 6 at 6:45 PM
Interesting GILD Put And Call Options For September 25thInteresting GILD Put And Call Options For September 25th
nasdaq.com - August 6 at 1:44 PM
Feds should march in on Covid drug remdesivir, state AGs say. Gilead says theyre wrong.Feds should 'march in' on Covid drug remdesivir, state AGs say. Gilead says they're wrong.
bizjournals.com - August 5 at 5:42 PM
Amgen (NASDAQ:AMGN) vs. Gilead Sciences (NASDAQ:GILD) Head-To-Head AnalysisAmgen (NASDAQ:AMGN) vs. Gilead Sciences (NASDAQ:GILD) Head-To-Head Analysis
americanbankingnews.com - August 5 at 5:02 AM
State attorneys general urge U.S. to let other firms make Gilead COVID-19 drugState attorneys general urge U.S. to let other firms make Gilead COVID-19 drug
finance.yahoo.com - August 5 at 1:47 AM
Gilead Sciences - Now That The COVID-19 Hype Is Over, Take A LookGilead Sciences - Now That The COVID-19 Hype Is Over, Take A Look
seekingalpha.com - August 4 at 5:15 AM
ViiV Healthcare infringement suit against Gilead to continue - judgeViiV Healthcare infringement suit against Gilead to continue - judge
seekingalpha.com - August 3 at 6:30 PM
Gilead Sciences: Remdesivir Remains A DistractionGilead Sciences: Remdesivir Remains A Distraction
seekingalpha.com - August 3 at 5:52 PM
Gilead Sciences (NASDAQ:GILD) PT Raised to $80.00 at CitigroupGilead Sciences (NASDAQ:GILD) PT Raised to $80.00 at Citigroup
americanbankingnews.com - August 3 at 4:30 PM
Gilead Stock Is Rising Because Covid-Treatment Sales Could Top $3 BillionGilead Stock Is Rising Because Covid-Treatment Sales Could Top $3 Billion
finance.yahoo.com - August 3 at 1:29 PM
Gilead Sciences (GILD) Buy Rating Reaffirmed at SVB LeerinkGilead Sciences' (GILD) Buy Rating Reaffirmed at SVB Leerink
www.americanbankingnews.com - August 3 at 6:16 AM
Gilead Sciences, Inc. (NASDAQ:GILD) to Post Q1 2021 Earnings of $1.75 Per Share, Piper Sandler ForecastsGilead Sciences, Inc. (NASDAQ:GILD) to Post Q1 2021 Earnings of $1.75 Per Share, Piper Sandler Forecasts
www.americanbankingnews.com - August 3 at 4:12 AM
Gilead Sciences (NASDAQ:GILD) Announces Quarterly  Earnings Results, Misses Expectations By $0.46 EPSGilead Sciences (NASDAQ:GILD) Announces Quarterly Earnings Results, Misses Expectations By $0.46 EPS
www.americanbankingnews.com - August 1 at 11:01 PM
Gilead Sciences (GILD) Buy Rating Reaffirmed at Cantor FitzgeraldGilead Sciences' (GILD) Buy Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - August 1 at 6:14 AM
Gilead Sciences (GILD) Q2 2020 Earnings Call TranscriptGilead Sciences (GILD) Q2 2020 Earnings Call Transcript
www.fool.com - August 1 at 2:17 AM
Remdesivir Maker Gilead Sciences Declares Dividend; Yield Is 3.9%Remdesivir Maker Gilead Sciences Declares Dividend; Yield Is 3.9%
finance.yahoo.com - July 31 at 11:14 PM
Gilead Sciences (NASDAQ:GILD) Shares Gap Down  After Earnings MissGilead Sciences (NASDAQ:GILD) Shares Gap Down After Earnings Miss
www.americanbankingnews.com - July 31 at 8:08 PM
Gilead Sciences: Buy And HoldGilead Sciences: Buy And Hold
seekingalpha.com - July 31 at 6:14 PM
Tech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack AttackTech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack Attack
www.fool.com - July 31 at 6:14 PM
Gilead Analysts Downplay Q2 Miss Amid Remdesivirs COVID-19 OpportunityGilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
finance.yahoo.com - July 31 at 6:14 PM
Gilead Sciences Breaks Below 200-Day Moving Average - Notable for GILDGilead Sciences Breaks Below 200-Day Moving Average - Notable for GILD
www.nasdaq.com - July 31 at 1:12 PM
Gilead (GILD) Misses on Q2 Earnings & Sales, Ups 20 GuidanceGilead (GILD) Misses on Q2 Earnings & Sales, Ups '20 Guidance
finance.yahoo.com - July 31 at 1:12 PM
Gilead Remdesivir Output Outlook Draws Analyst’s SkepticismGilead Remdesivir Output Outlook Draws Analyst’s Skepticism
www.thestreet.com - July 31 at 1:12 PM
Gilead Sciences, Inc. 2020 Q2 - Results - Earnings Call PresentationGilead Sciences, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 31 at 1:09 PM
Morgan Stanley Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $79.00Morgan Stanley Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $79.00
www.americanbankingnews.com - July 31 at 11:30 AM
Gilead Sciences (NASDAQ:GILD) Price Target Cut to $73.00 by Analysts at Credit Suisse GroupGilead Sciences (NASDAQ:GILD) Price Target Cut to $73.00 by Analysts at Credit Suisse Group
www.americanbankingnews.com - July 31 at 10:51 AM
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $74.00 at SunTrust BanksGilead Sciences (NASDAQ:GILD) Price Target Raised to $74.00 at SunTrust Banks
www.americanbankingnews.com - July 31 at 10:51 AM
Piper Sandler Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $85.00Piper Sandler Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $85.00
www.americanbankingnews.com - July 31 at 10:51 AM
Gilead Sciences (NASDAQ:GILD) PT Lowered to $87.00Gilead Sciences (NASDAQ:GILD) PT Lowered to $87.00
www.americanbankingnews.com - July 31 at 10:19 AM
Piper Sandler Research Analysts Lower Earnings Estimates for Gilead Sciences, Inc. (NASDAQ:GILD)Piper Sandler Research Analysts Lower Earnings Estimates for Gilead Sciences, Inc. (NASDAQ:GILD)
www.americanbankingnews.com - July 31 at 9:41 AM
Gilead Sciences (NASDAQ:GILD) Given New $76.00 Price Target at Wells Fargo & CoGilead Sciences (NASDAQ:GILD) Given New $76.00 Price Target at Wells Fargo & Co
www.americanbankingnews.com - July 31 at 7:41 AM
Gilead raises sales outlook to include COVID-19 treatment remdesivirGilead raises sales outlook to include COVID-19 treatment remdesivir
finance.yahoo.com - July 31 at 7:33 AM
US STOCKS-Nasdaq futures jump as Big Tech booms during pandemicUS STOCKS-Nasdaq futures jump as Big Tech booms during pandemic
finance.yahoo.com - July 31 at 7:33 AM
Gilead Sciences (NASDAQ:GILD) Issues FY20 Earnings GuidanceGilead Sciences (NASDAQ:GILD) Issues FY20 Earnings Guidance
www.americanbankingnews.com - July 31 at 12:36 AM
10,53410,534
www.businesswire.com - July 30 at 11:08 PM
Gilead Sciences (GILD) CEO Daniel ODay on Q2 2020 Results - Earnings Call TranscriptGilead Sciences' (GILD) CEO Daniel O'Day on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - July 30 at 11:08 PM
Gilead Sciences' Revenue and Earnings Slip in Second QuarterGilead Sciences' Revenue and Earnings Slip in Second Quarter
finance.yahoo.com - July 30 at 11:08 PM
Gilead Sciences (NASDAQ:GILD) Releases FY 2020
After-Hours Earnings GuidanceGilead Sciences (NASDAQ:GILD) Releases FY 2020 After-Hours Earnings Guidance
www.americanbankingnews.com - July 30 at 7:54 PM
Gilead Sciences Revenue and Earnings Slip in Second QuarterGilead Sciences' Revenue and Earnings Slip in Second Quarter
www.fool.com - July 30 at 7:46 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.